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Covalent closed circular RNAs (circRNAs) can act as a bridge between non-coding
RNAs and coding messenger RNAs. CircRNAs are generated by a back-splicing
mechanism during post-transcriptional processing and are abundantly expressed in
eukaryotic cells. CircRNAs can act via the modulation of RNA transcription and protein
production, and by the sponging of microRNAs (miRNAs). CircRNAs are now thought
to be involved in many different biological and pathological processes. Some studies
have suggested that the expression of host circRNAs is dysregulated in several types of
virus-infected cells, compared to control cells. It is highly likely that viruses can use
these molecules for their own purposes. In addition, some viral genes are able to
produce viral circRNAs (VcircRNA) by a back-splicing mechanism. However, the viral
genes that encode VcircRNAs, and their functions, are poorly studied. In this review, we
highlight some new findings about the interaction of host circRNAs and viral infection.
Moreover, the potential of VcircRNAs derived from the virus itself, to act as biomarkers
and therapeutic targets is summarized.
Keywords: circular RNA, VcircRNA, viral infection, biomarker, back-splicing, epigenetics
Abbreviations: A3BS, alternative 3′ back-splicing; A5BS, alternative 5′ back-splicing; AGO, argonaute; ASCC, anal
squamous cell carcinoma; BART, Bam HI-A region rightward transcript; circBART, EBV-derived circRNA; circE7, HPV-E7
derived circRNA; circRNAs, covalent closed circular RNAs or circular RNAs; CMV, cytomegalovirus; EBER, EBV-encoded
RNA; EBV, Epstein Barr virus; EMT, epithelial-mesenchymal transition; HBV, hepatitis B virus; HCC, hepatocellular
carcinoma; HDAg, hepatitis delta antigen; HDV, hepatitis D virus; HHV, human herpesvirus; HPV, human papillomavirus;
HSV, herpes simplex virus; IAV, influenza A virus; IRES, internal ribosome entry site; KSHV, Kaposi’s sarcoma-
associated herpesvirus; lncRNA, long noncoding RNA; MBL, mannose-binding lectin; NGS, next-generation sequencing;
NPC, nasopharyngeal carcinoma; PAN, polyadenylated nuclear RNA; PEL, primary effusion lymphoma; RNA-seq, RNA-
sequencing; rRNA, ribosomal ribonucleic acid; SA409, splice acceptor 409; SD226, splicing between splice donor 226; snRNA,
small nuclear RNA; snRNPs, small nuclear ribonucleoproteins; TGEV, transmissible gastroenteritis virus; tRNA, transfer
ribonucleic acid; VcircRNAs, virus-encoded circRNAs; VZV, varicella-zoster virus.
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INTRODUCTION
Single-stranded circular RNAs (circRNAs) belong to the
non−coding RNA family. Unlike linear RNAs, they are take
the form of a covalently closed continuous loop with neither
5′ capping nor 3′ polyadenylation, and are formed by a back-
splicing process (Guo et al., 2014; Holdt et al., 2018). Sanger et al.
(1976) originally discovered the presence of circRNAs in a viroid-
infected plant using electron microscopy in 1970. Later, the
presence of circRNA was detected in the hepatitis D virus (HDV)
and in yeast mitochondria (Arnberg et al., 1980). The first study
to confirm the presence of circRNAs in human cells by Nigro et al.
(1991), reported the detection of circular transcripts derived from
the tumor suppressor gene DCC in several human tumor cell
lines. Recently, with the advent of new sequencing technologies,
such as next-generation sequencing (NGS), a growing number of
circRNAs have been reported (Hanan et al., 2017; Wang et al.,
2017; Zhang Z.-C. et al., 2018; Zaiou, 2019), and have now
become a “hot topic.”
Since some circRNAs have the ability to encode proteins,
they have therefore been suggested as a crucial bridge between
non-coding RNAs and coding RNAs (Braicu et al., 2019). To
date, the function(s) of several circRNAs have been identified,
including the sponging of microRNA (miRNA), regulation of
RNA transcription and protein production, and the translation
of proteins and peptides (Li J. et al., 2015). Considering the
multifunctional nature of circRNAs, they may be involved
in many biological and pathological processes, which could
influence the progression of diseases such as cancer and viral
infections. In cancer it has been suggested that circRNAs could
affect the malignant phenotype through regulating cancer-related
pathways, and could exert either an anti-cancer activity or a pro-
cancer activity. Therefore, these molecules could either act as
tumor suppressors or alternatively as oncogenes depending on
the tumor type and stage (Wang et al., 2017), and could therefore
serve as a therapeutic target in the treatment of cancer.
Moreover, the unique covalent closed-loop structure of
circRNAs makes them insensitive to the enzyme activity of
ribonucleases (Harland and Misher, 1988). The expression levels
of circRNAs are generally lower than those of messenger RNAs
(mRNAs) (Jeck et al., 2013; Guo et al., 2014; Shang et al.,
2019). However, circRNAs mostly act in a tissue and cell type-
specific manner, and have been found to be stably expressed in
several biological materials including saliva, tissue, blood, and
exosomes. Therefore, circRNAs could be potential biomarkers in
the diagnosis and prognosis of several different diseases (Zhang
Z. et al., 2018; Naeli et al., 2019). Up to now, only relatively
few studies have been conducted on the interaction between
viruses and host circRNAs; however, it has been reported that
the expression patterns of host circRNAs are altered in virus-
infected cells and patients compared to the control groups (Cui
et al., 2018; Shi et al., 2018; Zheng et al., 2018; Yu T. et al.,
2019). Therefore, it has been proposed that viruses are likely
to use these molecules for their own progression. It has also
been observed that some viral genes are able to produce viral
circRNA (VcircRNA) molecules through back-splicing (Toptan
et al., 2018; Ungerleider et al., 2019; Zhao et al., 2019b), but the
viral genes that can encode circRNAs and their functions are
poorly studied. In this review, we will first briefly discuss the
biogenesis, and function of circRNAs, and then highlight some
new findings concerning the interaction of host circRNAs with
viral infections. Lastly, circRNAs derived from the virus genome
and their potential as biomarkers or therapeutic targets for viral
diseases are summarized.
THE BIOGENESIS OF circRNAs
In eukaryotic cells, the splicing of precursor mRNA (pre-mRNA)
is catalyzed by spliceosomes. The spliceosome is an assembly
of small nuclear ribonucleoproteins (snRNPs) and other protein
factors that act to join together exons, and remove introns
(Valadkhan, 2005). During splicing, if the upstream 5′ splice-
site (donor site) is joined to the downstream 3′ splice site
(acceptor site) this leads to the production of linear (m)RNAs.
However the spliceosome can also generate circRNAs during the
processing of pre-mRNA, pre-transfer ribonucleic acid (tRNA),
and pre-ribosomal ribonucleic acid (rRNA) molecules (Zhang
et al., 2017). These loop structures can originate from exons
or from introns in either a single sequence or two different
sequences (Xin et al., 2017). CircRNAs are considered to be a
highly stable class of long non-coding RNAs, and are believed to
be an important bridge between non-coding RNAs and coding
RNAs (Braicu et al., 2019). CircRNAs are generally divided
into three categories based on their components. Firstly, exonic
circRNAs (ecircRNAs) are exclusively composed of exons, and
represent the largest group of circRNAs. Secondly, intronic
circRNAs (ciRNA) are exclusively composed of introns. Thirdly,
exon-intron circRNAs (elciRNA) contain both exon and intron
related sequences (Figure 1) (Wang et al., 2019). Intergenic
circRNA is another non-exonic circRNA identified by a circRNA
identifier (CIRI). This integrated circRNA is formed by two
intronic circRNA fragments (ICFs) flanked by GT-AG splicing
signals acting as the splice donor (SD) and splice acceptor (SA)
sites of the circular junction (Geng et al., 2018). Studies using
different techniques have shown that ecircRNAs are localized
within the cytoplasm (Jeck and Sharpless, 2014). On the other
hand, ciRNA and elciRNA are predominantly localized within the
nucleus (Meng et al., 2017). The “direct back-splicing” and “lariat
formation” are the two main mechanisms that can lead to the
conversion of pre-mRNAs into circRNAs (Qu et al., 2015; Yang
et al., 2017; Braicu et al., 2019). In the back splicing process, the
downstream 5′ donor site is linked to the upstream 3′ acceptor
site resulting in the production of circRNAs (Kristensen et al.,
2019; Zhao et al., 2019c). Interestingly, multiple circRNAs can be
generated through two different types of back-splicing, including
alternative 5′ back-splicing (A5BS), and alternative 3′ back-
splicing (A3BS). A5BS occurs when two or more 5′ downstream
back-splice sites bind to the same upstream 3′ back-splice site in
a reverse orientation. Similarly, A3BS occurs when two or more
upstream 3′ back-splice sites bind to the same downstream 5′
back-splice site (Qu et al., 2015; Dong et al., 2018).
The two different types of the lariat formation mechanism, are
“exon skipping” and “intron−pairing−driven” circularization
Frontiers in Microbiology | www.frontiersin.org 2 July 2020 | Volume 11 | Article 1853
fmicb-11-01853 July 30, 2020 Time: 18:36 # 3
Nahand et al. Circular RNAs in Viral Infections
FIGURE 1 | Biogenesis of circRNAs. Pre-mRNA can be processed through either canonical splicing to produce linear RNAs (left) or backsplicing to generate
circRNAs (right). CircRNAs are mainly divided into three categories based on their components. Exonic circRNAs (ecircRNAs) are exclusively composed of exons
and represent the largest group of circRNAs, intronic circRNA (ciRNA) are exclusively composed of introns, and exon-intron circRNA (elciRNA) are exon-intron
sequences. In this figure, arrows show the splicing events for generating the products, blue lines show introns, and colored lines (red/yellow) show exons.
(Wang et al., 2015). In intron−pairing−driven circularization,
the 5′ end of the pre-mRNA is cleaved by the U1 small nuclear
RNA (snRNA), and the 5′- and 2′-bases between the guanidine
and adenosine are ligated together. The processed intronic lariat
is retained in a circular form within the nucleus (Konarska et al.,
1985; Hansen et al., 2013; Braicu et al., 2019). Exon skipping
occurs naturally only at a low frequency (Goyenvalle et al., 2004).
In exon skipping a “hetero-lariat” is formed that contains both
introns and exons (Suzuki et al., 2016; Zhu et al., 2017; Braicu
et al., 2019). This process could continue until all the introns have
been removed, and only circRNAs containing exonic sequences
are formed (Yang et al., 2017).
Some studies have shown that various viruses can encode
circRNAs by alternative splicing of the viral mRNAs (Bodescot
and Perricaudet, 1986; Purcell and Martin, 1993). Thus, viruses
can produce VcircRNAs (Zhao et al., 2019b) using a back-
splicing mechanism (Toptan et al., 2018). However, only few
studies have been performed on this topic and more experimental
studies are needed.
THE FUNCTIONS OF circRNAs
Considering the great diversity of circRNAs and their many
individual targets, it is to be expected that circRNAs will play
several key roles within the cell, but not all of them have yet
been well characterized. However, some cellular and molecular
roles of circRNAs have been identified (Ruskin and Green, 1990;
Vicens and Westhof, 2014). As mentioned above, circRNAs can
be derived from introns (intronic circRNA or ciRNA), exons
(exonic circRNA or ecircRNA) and exon-intron sequences (exon-
intron circRNA or elciRNA) (Zhang et al., 2013; Zhang et al.,
2014; Chen et al., 2015; Li Z. et al., 2015). Some elciRNAs
and ciRNAs are found in the nucleus and are likely to play a
regulatory function in gene transcription, whereas ecircRNAs
are predominantly found in the cytoplasm, and are involved in
post-transcriptional regulation (Haddad and Lorenzen, 2019).
The structural examination of some circRNAs has shown that
they contain N6-methyladenosine modifications or an internal
ribosome entry site (IRES), and have the potential to be efficiently
translated into proteins (Yu and Kuo, 2019). Depending on
the type of protein produced, they could play important roles
within the cell. For example, Yang et al. (2019) found that circ-
FBXW7 was abundantly expressed in the normal human brain
tissue, and reported that circ-FBXW7 encodes the FBXW7-185aa
protein. The FBXW7-185aa protein inhibits cell proliferation
and tumorigenesis, while its down-regulation is associated with
the induction of a malignant phenotype in cancer cells (Yang
et al., 2019). Additionally, circRNAs may also affect the activity of
proteins, and are probably involved in the modulation of protein–
protein interactions, protein binding, and protein sorting (Du
et al., 2017). For example, circRNA CDR1 interacts strongly with
argonaute (AGO) proteins, which are essential components of the
RISC complex (Memczak et al., 2013).
CircRNAs could also regulate the activity of miRNAs via a
novel mechanism (Kulcheski et al., 2016). Endogenous circRNAs
can function as miRNA sponges, to negatively regulate the
activity of miRNAs by removing them from their site of action
(Hansen et al., 2013; Memczak et al., 2013). Since miRNAs control
many biological events, circRNAs could influence these processes
through a miRNA sponging effect (Kulcheski et al., 2016). It has
been shown that several miRNA sponges may be associated with
human disease, such as Alzheimer’s, Hirschsprung’s, diabetes,
osteoarthritis, and several types of cancer (Lukiw, 2013; Wang
et al., 2016; Zhao et al., 2016; Han et al., 2017; Peng et al., 2017;
Zhao et al., 2017; Zhou and Yu, 2017; Zhou Z.-B. et al., 2018;
Kristensen et al., 2018).
For example, it has been shown that some circRNAs can
contribute to cancer progression by sponging tumor-suppressive
miRNAs, or alternatively suppress the cancer phenotype via
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sponging of oncogenic miRNAs. It has generally been observed
that tumor suppressor circRNAs are down-regulated in cancers,
while oncogenic circRNAs are up-regulated. For instance, Hao
et al. (2019) reported that circ_0007534 was over-expressed
in patients with pancreatic ductal adenocarcinoma. They also
found that ectopic expression of circ_0007534 caused increased
proliferation, invasion, and migration in the PDAC cell line.
This oncogenic effect of circ_0007534 was mediated by sponging
of miR-892b and miR-625 (Hao et al., 2019). Circ_0026344
was found to be down-regulated in colorectal cancer, while
the expression level of miR-31 and miR-21 was increased in
colorectal cancer tissue. Further analysis demonstrated that
over-expression of circ_0026344 decreased tumor growth and
increased apoptosis in cell lines, through sponging of miR-21 and
miR-31 (Yuan et al., 2018).
However, up to now only a few studies have been performed
on the function of circRNAs in viral infections, and the role
they may play in inhibiting or enhancing virus replication is not
well understood. A summary of the circRNA functions is shown
in Figure 2.
HOST circRNAs AND VIRAL INFECTIONS
As discussed above, it has been shown that the deregulation
of circRNA expression in cancer cells, i.e., down-regulation or
up-regulation, can contribute to the malignancy of cancer cells
(Wu et al., 2019). However, it is not yet clear whether the
aberrant expression of circRNAs in virus-infected cells, ultimately
contributes to viral replication or not. It has been demonstrated
that viral infections can remodel the entire transcriptome
landscape of host cells (Park et al., 2015; Hu et al., 2016).
One important effect is to improve the viral replication cycle
through modifying transcriptomic responses related to antiviral
immunity and cellular apoptosis. This common strategy has been
observed in many different viral infections (Gao et al., 2017a;
Martin et al., 2017; Wang et al., 2017). HSV-1 infection, in
addition to altering the expression of cellular genes, can affect
RNA processing in the host cells leading to changes in alternative
polyadenylation and splicing in the host transcriptome (Zheng
et al., 2017; Shi et al., 2018). An interaction between viruses
and circRNAs was observed in a study by Li et al. (2017).
FIGURE 2 | Schematic of circRNA functions. CircRNAs might function as miRNA sponges by competing for the binding of miRNA sequences, lessening the impact
of miRNA-mediated regulation of gene expression. CircRNAs might function as protein sponges. Some circRNAs might control the expression of proteins by
sequestering mRNA translation start sites. CircRNAs might be translated to create functional proteins.
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They reported that the transcription factor NF90/NF110 (derived
from interleukin enhancer binding factor, ILF3) could regulate
the biogenesis and function of circRNAs. Upon viral infection,
these factors led to the down-regulation of circRNA levels
(Li et al., 2017).
Recently, Shi et al. (2018) examined the profile of the circRNA
transcriptome in HSV-infected cells. In this study, the aberrant
circRNA expression profile in the HSV-1-infected KMB17 cell
line was investigated using deep RNA sequencing. The results
showed that the expression levels of 536 separate circRNAs were
significantly dysregulated after HSV-1 infection, and of these, 348
circRNAs were down-regulated and 188 were up-regulated. The
expression levels of five circRNAs (circRNA7231, circRNA3683,
circRNA3046, circRNA6783, and circRNA7752) were measured
by real time quantitative reverse transcription (RT-qPCR), and it
was found that their expression was significantly increased after
infection with HSV-1 (Shi et al., 2018). However, the function and
interaction of these circRNAs with the HSV-1 virus, and whether
they could be used as diagnostic biomarkers or therapeutic targets
is still unclear.
Cervical cancer is the fourth most common cancer among
women throughout the world (Bhadelia, 2019). Persistent
infection with the high risk type of human papillomaviruses
(HPV-16 and HPV-18) is the main cause of the progression
of papilloma lesions to cervical cancer, and is found in more
than 70% of cases (Ghittoni et al., 2010). HPV E6 and E7
oncoproteins play a critical role in the transformation of cervical
cells by interfering with the p53 and pRb pathways, respectively
(Burroni et al., 2013). In addition, HPV E6 and E7 oncoproteins
can modulate the expression of cellular miRNAs, which may
contribute to the tumorigenesis of cervical cancer cells (Nahand
et al., 2019). Since circRNAs act as sponges for miRNAs, the
virus is likely to indirectly alter the expression level of miRNAs
by affecting circRNAs. Current studies suggest that circRNAs
have the potential to be used as diagnostic biomarkers in cervical
cancer (Chaichian et al., 2019). Gao et al. (2017b) demonstrated
that hsa_circ_0018289 was over-expressed in cervical cancer
cells, and knockdown of this circRNA could suppress the
migration, proliferation, and invasion of cervical cancer cells.
They suggested hsa_circ_0018289 may play an oncogenic role in
the tumorigenesis of cervical cancer (Gao et al., 2017b).
One study evaluated the circRNA expression profile in
cervical cancer cells infected with HPV16 E7. Using a
microarray approach, they found that 526 separate circRNAs
had significantly altered expression levels (174 down-regulated
352 up-regulated) (Zheng et al., 2018). In order to confirm
these results, eight circRNAs with different expression levels were
measured using the qRT-PCR method, and it was found that the
results of both methods were in agreement. The finding that the
expression pattern of circRNAs in HPV-16 E7 infected cells was
altered (Zheng et al., 2018), provided new insights into potential
therapeutic targets and candidate biomarkers in cervical cancer
associated with HPV.
MicroRNAs are involved in many cellular biological processes,
including inflammation, cellular differentiation, apoptosis, and
also in viral infection (Hagen and Lai, 2008; Hulsmans and
Holvoet, 2013; Sadri et al., 2019). Transmissible gastroenteritis
virus (TGEV) is a member of the Coronavirus family with a
positive-sense single-stranded RNA genome, which emerged as a
cause of severe gastroenteritis in pigs (Laude et al., 1990). TGEV
can activate the NF-κB pathway resulting in severe inflammation
in the epithelial cells of porcine intestines (Ma et al., 2014).
Ma et al. (2018) analyzed the expression profile of circRNAs,
miRNAs, and mRNAs in TGEV-infected IPEC-J2 (intestinal
porcine epithelial cell-jejunum 2) cell line using NGS technology.
They observed that miR-22 was over-expressed in TGEV infected
cells, and suggested that ssc_circ_009380 by sponging of miR-22
was able to trigger NF-κB pathway activity. It is known that miR-
22 exerts its anti-inflammatory effects via targeting IL-6, CCL5
and DDX58 (Ma et al., 2018). Moreover, it was demonstrated that
miR-22 could attenuate myocardial ischemia-reperfusion injury
in rats via an anti-inflammatory mechanism (Yang et al., 2016).
The hepatitis B virus (HBV) belongs to the Hepadnaviridae
family, and between 5 and 10% of HBV-infected patients develop
a chronic liver infection about 6 months after the acute infection
(Mayerat et al., 1999). Chronic HBV infection can cause serious
liver diseases, such as cirrhosis and hepatocellular carcinoma
(HCC) (Sinn et al., 2015). The progression of HBV infection
in many individuals is limited by the host immune response.
However, in others the infections becomes chronic due to
comparatively weak T-cell responses against HBV, suppression of
NK cell function by several immunomodulatory cytokines, and
ineffective adaptive responses against HBV viral infected cells
(Mayerat et al., 1999; Tan et al., 2015). Other factors, such as
alcohol, aflatoxin, gut microbiota, mannose-binding lectin (MBL)
genotype, and also miRNAs, can affect the progression of chronic
hepatitis B (Ohnishi et al., 1982; Handin et al., 2003; Chong
et al., 2005; Sagnelli et al., 2018; Sadri Nahand et al., 2019).
Evidence suggests that some circRNAs are associated with the
carcinogenesis process of HCC (Fu et al., 2018). Zhu et al. (2018)
showed that hsa_circ_0067934 by sponging of miR−1324, could
alter the FZD5/Wnt/β−catenin signaling pathway, which was
involved in migration, proliferation, and invasion of HCC cells.
However, the role of HBV infection in altering the expression
of circRNAs, which may then contribute to liver disease, is
poorly characterized. Yang et al. (2016, 2017, 2019) investigated
the deregulation of circRNAs in hepatitis B-related HCC, and
found that circRNA_100338 was significantly over-expressed in
HCC tissue. They also found that circRNA_100338 could act
as a miR-141-3p sponge in HCC tissue, and suggested that
circRNA_100338 could be a new biomarker for the diagnosis
of HBV-associated HCC (Huang et al., 2017). Yu J. et al.
(2019) examined the expression of circRNAs in plasma and
HCC tissues from infected patients by microarray and qRT-
PCR techniques. They reported that there was a positive
correlation between the expression levels of hsa_circ_0139897,
hsa_circ_0000976, and hsa_circ_0007750 in the patient samples,
and they were significantly increased after hepatectomy (Yu J.
et al., 2019). Data concerning the role of circRNAs as diagnostic
or therapeutic biomarkers in HBV-HCC is limited and needs
further investigation.
Autophagy is a form of programmed cell death, and
is a highly conserved cellular process designed to dispose
of damaged cellular organelles or protein aggregates
Frontiers in Microbiology | www.frontiersin.org 5 July 2020 | Volume 11 | Article 1853
fmicb-11-01853 July 30, 2020 Time: 18:36 # 6
Nahand et al. Circular RNAs in Viral Infections
(Pourhanifeh et al., 2020). Autophagy is activated in many
viral infections such as HSV-1, HBV, and influenza A virus
(IAV). Autophagy has been reported to either inhibit or stimulate
the replication of some viruses, and plays a critical role in
modulating cell survival (Ahmad et al., 2018). Additionally,
it has been observed that viral proteins and noncoding RNAs
produced during viral infections, can regulate autophagy in the
host cells, which may contribute to escape from the immune
system, release of viruses from cells, and viral replication
(Kudchodkar and Levine, 2009; Fu et al., 2015; Wu et al.,
2016). circRNAs have the ability to either attenuate or activate
autophagy depending on the conditions (Du et al., 2018; Zhou
L.-Y. et al., 2018), and therefore viruses may also affect autophagy
by altering the expression of circRNA. Recently, it was reported
that the expression level of circ-GATAD2A was up-regulated
during infection of A549 cells with IAV. Furthermore, after the
knockdown of circ-GATAD2A within the cells, H1N1 replication
was suppressed and autophagy was promoted. In agreement,
the up-regulation of circ-GATAD2A in A549 cells-infected with
H1N1 promoted virus replication and also inhibited autophagy.
Overall, the results of this study suggested that this circRNA
could promote H1N1 replication by suppressing autophagy
(Yu T. et al., 2019), and this finding might be useful for
therapeutic purposes.
The role of circRNAs in viral replication has only so far
been studied to a limited extent, however, given the significant
changes observed in the circRNA expression profile during viral
infections, we believe that viruses are likely to use this effect to
their advantage. Reports of the deregulation of circRNAs during
viral infections are shown in Table 1.
VIRUS-ENCODED circRNAs
Viral infections in both humans and animals have been reported
to occur with increased frequency in recent years. There are
several types of viral disease, according to the underlying virus.
HDV was the first human viral pathogen to be found to possess a
circRNA within the genome (Kos et al., 1986). This circRNA can
encode only one protein, hepatitis delta antigen (HDAg) (Farci,
2003). The Herpesviridae is a large family of DNA viruses, which
can be categorized into three subfamilies: Alphaherpesvirinae,
e.g., herpes simplex virus (HSV)-1, 2, varicella-zoster virus
(VZV), Betaherpesvirinae, e.g., cytomegalovirus (CMV), human
herpes virus (HHV)-6, 7, and Gammaherpesvirinae, e.g., Epstein
Barr virus (EBV) and Kaposi’s sarcoma-associated herpes virus
(KSHV). Almost all herpes viruses remain latent after the primary
infection has subsided and are later reactivated under certain
conditions (Pellett and Roizman, 2013). The viral replication and
the expression of viral genes in the latent phase are limited, and
this accounts for the ability of the virus to escape from the host
immune response (Grinde, 2013). HPV is another viral infection
that is passed between people through skin-to-skin contact. As
discussed earlier, persistent infection with HPV-16 and HPV-18
is the main cause of the papilloma lesions that are precursors to
cervical cancer, and is found in more than 70% of cases (Ghittoni
et al., 2010). Anal squamous cell carcinoma (ASCC) is a rare
malignancy, but high-risk strains of HPV have been implicated
in 70–90% of ASCC cases (Martin et al., 2018).
Hepatitis D virus produces its circRNA molecules by using
the cellular machinery and the rolling-circle mechanism. The
connection of both ends of the RNA molecules by formation
of 3′–5′ or 2′–5′ phosphodiester bonds leads to the formation
of circRNA molecules (Reid and Lazinski, 2000; Eger et al.,
2018). Two advantages of the circularization process of the
HDV genome or viral encoded circRNAs could be suggested: (a)
escape from recognition via innate immune pattern recognition
receptors such as RIG-I and MDA-5; and (b) protection against
degradation by intracellular exonucleases (Eger et al., 2018).
The innate immune system, the first line of host defense, is
very important against pathogens. It contains pattern recognition
receptors which respond to some specific structures that are
typical of pathogens (Mogensen, 2009). Protein kinase R
(PKR) is one of the receptors that recognize long dsRNAs
(>33 bp) in the cytoplasm, and inhibits synthesis of protein.
Although PKR should be readily activatable if needed, it should
remain in an inactive state to prevent autoimmunity and
inappropriate reactions. Studies have shown that activation
of PKR can be inhibited by binding to the adenovirus
small-noncoding VAI RNA or short (16–33 bp) dsRNAs. Liu
C. X. et al. (2019) found that endogenous circRNAs could
bind to PKR (Kitajewski et al., 1986; Zheng and Bevilacqua,
2004). Importantly, by comparing the binding profiles of
circular and linear RNAs with the same base sequence, they
found that circRNAs could bind more strongly to PKR
than linear RNAs. This result suggested that the secondary
structures of circRNAs and linear RNAs are different. In
fact, structural mapping showed that circRNAs inside cells
could form stable secondary structures which contained short
(16–26 bp) imperfect duplexes, whereas the linear RNAs
were folded into unstable and more dynamic structures
(Liu C. X. et al., 2019).
As mentioned above, alternative splicing is a key post-
transcriptional mechanism involved in the production of
circRNA molecules from pre-mRNAs (Eger et al., 2018). One
way that the virus could produce multiple products from a
single gene, is alternative splicing. Since this mechanism occurs
in the nucleus, DNA viruses (e.g., Adenoviridae, Herpesviridae,
Papillomaviridae, Polyomaviridae, and Hepadnaviridae) (Ge and
Manley, 1990; Tormanen et al., 2006; Verma and Swaminathan,
2008; Mole et al., 2009; Li et al., 2010; Guan et al., 2011)
and some RNA viruses (e.g., Retroviridae, Bornaviridae, and
Orthomyxoviridae) (Hope, 1999; Tomonaga et al., 2000; Robb
and Fodor, 2012) that all replicate within the nucleus, may be
capable of producing circRNAs. Recently, the RNA-sequencing
technique (RNA-seq) has been used to identify the expression
of circRNAs, and many results have been confirmed by RT-
qPCR (Li and Han, 2019). RNA-seq was applied to evaluate
the expression level of RNAs, and to survey the overall RNA
population, including long noncoding RNA (lncRNA), small
RNA, rRNA, and circRNA (Wang et al., 2009; Ingolia et al., 2012).
The following methods have employed for different purposes
in the RNA-seq experiments: (a) RiboMinus treatment was
used for the accurate comparison between circRNA and mRNA
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TABLE 1 | Cellular circRNAs and viral infections.
circRNA Virus Dysregulation Model Type of cell line References
hsa_circ_0003046 (circRNA3046) HSV-1 Up In vitro KMB17 Shi et al. (2018)
hsa_circ_0003683 (circRNA3683) HSV-1 Up In vitro KMB17 Shi et al. (2018)
hsa_circ_0007752 (circRNA7752) HSV-1 Up In vitro KMB17 Shi et al. (2018)
hsa_circ_0007231 (circRNA7231) HSV-1 Up In vitro KMB17 Shi et al. (2018)
hsa_circ_0006783 (circRNA6783) HSV-1 Up In vitro KMB17 Shi et al. (2018)
hsa_circ_0051620 HPV-16 (E7) Up In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0052602 HPV-16 (E7) Up In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0005389 Chronic hepatitis B Up Human - Zhou T. C. et al. (2018)
hsa_circ_0000038 Chronic hepatitis B Up Human - Zhou T. C. et al. (2018)
hsa_circ_0100381 HBV-related HCC Up Human - Wang et al. (2018)
hsa_circ_0103489 HBV-related HCC Up Human - Wang et al. (2018)
hsa_circ_0104351 HBV-related HCC Up Human - Cui et al. (2018)
hsa_circ_0102814 HBV-related HCC Up Human - Cui et al. (2018)
hsa_circ_0103489 HBV-related HCC Up Human - Cui et al. (2018)
hsa_circ_0102109 HBV-related HCC Up Human - Cui et al. (2018)
hsa_circ_0100381 HBV-related HCC Up Human - Cui et al. (2018)
hsa_circ_0027089 HBV-related HCC Up Human (plasma) - Zhu et al. (2019)
hsa_circ_0000976 HBV-related HCC Up Human (tissue and plasma) Huh-7, Hep-G2 Yu J. et al. (2019)
hsa_circ_0007750 HBV-related HCC Up Human (tissue and plasma) Huh-7, Hep-G2 Yu J. et al. (2019)
hsa_circ_0139897 HBV-related HCC Up Human (tissue and plasma) Huh-7, Hep-G2 Yu J. et al. (2019)
hsa_circ_0030753 (circ-GATAD2A) Influenza (H1N1) Up In vitro A549 cells Yu T. et al. (2019)
hsa_circ_0001400 KSHV Up In vitro HUVEC, 293T cells Tagawa et al. (2018)
hsa_circ_0001741 KSHV Up In vitro HUVEC, 293T cells Tagawa et al. (2018)
chi_circ_7880 (circRNA7880) ORFV Up In vitro GSF cells Pang et al. (2019)
hsa_circ_0048867 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0038475 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0035918 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0056353 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0026527 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0037213 HPV-16 (E7) Down In vitro C33A, CaSKi cells Zheng et al. (2018)
hsa_circ_0102904 HBV-related HCC Down Human - Cui et al. (2018)
hsa_circ_0001225 HBV-related HCC Down Human - Cui et al. (2018)
hsa_circ_0101092 HBV-related HCC Down Human - Cui et al. (2018)
hsa_circ_0101764 HBV-related HCC Down Human - Cui et al. (2018)
hsa_circ_0100327 HBV-related HCC Down Human - Cui et al. (2018)
hsa_circ_0000650 Chronic hepatitis B Down Human - Zhou T. C. et al. (2018)
hsa_circ_0101764 HBV-related HCC Down Human - Wang et al. (2018)
ssc_circ_0009380 (circEZH2) TGEV Down In vitro IPEC-J2 Ma et al. (2018), Zhao et al. (2019d)
chi_circ_1001 (circRNA1001) ORFV Down In vitro GSF cells Pang et al. (2019)
chi_circ_1684 (circRNA1684) ORFV Down In vitro GSF cells Pang et al. (2019)
chi_circ_3127 (circRN3127) ORFV Down In vitro GSF cells Pang et al. (2019)
mmu_circ_001273 (circRNA1273) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001040 (circRNA1040) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001005 (circRNA1005) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001013 (circRNA1013) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001220 (circRNA1220) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001088 (circRNA1088) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
mmu_circ_001195 (circRNA1195) SV40 - In vitro AGMK-derived Vero cells Shi et al. (2017)
expression levels; (b) RNase R and RiboMinus treatment was used
for the comprehensive profiling of circRNAs; and (c) poly(A)
enrichment was used to increase the concentrations of lncRNA
and mRNA (Ji et al., 2019).
According to the different expression patterns of EBV genes,
at least three distinct latent phases (I, II, and III) have been
identified (Münz, 2015). In addition to its coding RNAs, the
EBV virus can also express non-coding RNAs. It has been
shown that the intronic regions of the Bam HI-A region
rightward transcript (BART) gene of EBV is capable of expressing
many non-coding RNAs (ncRNA), including the small non-
coding EBV-encoded RNA 1 (EBER1) and EBER2 (Fok et al.,
2006; Verhoeven et al., 2019). Unlike EBV, differential gene
expression in various types of Karposi’s sarcoma tumor has been
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described (Dittmer and Damania, 2013). During latent infection
with KSHV a number of non-coding RNAs have been detected,
including miRNAs and the polyadenylated nuclear RNA (PAN)
(Samols et al., 2007; Conrad, 2016; Toptan et al., 2018).
PAN transcripts are important for KSHV replication and are
abundantly expressed during lytic replication, but are found only
in low levels during the latent phase (Conrad, 2016). The viral
genes encoding circRNAs in many viruses have not yet been
fully investigated.
Toptan et al. (2018), for the first time investigated the
VcircRNAs encoded by EBV and KSHV in tumor samples and
cell lines. In this study RNA-seq was used to identify VcircRNAs
after treatment with RNase R. RNase R-resistant RNA sequencing
showed that both EBV and KSHV could encode several circRNAs.
They observed that in EBV-positive PTLD samples, there were
several EBV-derived circRNAs (circBARTs). These were both
exon-intron and exon-only circRNAs, formed by back-splicing of
BART transcripts. Similarly, circBARTs derived from BART are
expressed in all types of latent EBV infection. The authors found
that circBARTs were found in all tumors associated with EBV, and
suggested that circBARTs could play a role in the reproductive
ability of EBV-positive tumor cells. Furthermore, the sequencing
of circRNAs within KSHV-infected primary effusion lymphoma
(PEL) cells showed that KSHV circRNAs (including circvIRF4
and circPAN/K7.3) were expressed in these cells, and were
found to originate from the vIRF4 locus and the PAN region,
respectively (Toptan et al., 2018). These VcircRNAs may provide
a novel approach for diagnostic biomarkers and therapy for
KSHV and EBV associated malignancies.
Huang et al. (2019) used RNA-seq to investigate whether EBV
is able to encode circRNAs in EBV-infected cell lines, including
Akata (latency I), AGS-EBV (latency I), SNU-719 (latency I),
C666-1 (latency II), and EBV-positive nasopharyngeal carcinoma
(NPC) tissue samples. They found that ebv-circRPMS1 originated
from exons 2–4 of the RPMS1 gene by back-splicing (Figure 3)
(Huang et al., 2019). In another study, the role of EBV-
encoded circRPMS1 in NPC tumorigenesis was examined (Liu
Q. et al., 2019), and it was found that circRPMS1 expression
was correlated with a shorter survival time, and was further
up-regulated in metastatic NPC samples. Moreover, knockdown
FIGURE 3 | Formation and function of ebv-circRPMS1in EBV-infected NPC cells. Genomic location of the RPMS1 gene in EBV-BART region and ebv-circRPMS1
that originated from exon 2–4 of the RPMS1 gene by back-splicing. CircRPMS1 may be involved in the oncogenesis of NPC via sponging of miR-31, miR-451, and
miR-203.





















TABLE 2 | Viral circular RNAs (VcircRNAs) in viral infections.
VcircRNAs Virus Derived from Model Cell line localized in
cytoplasm/nucleus
Note References
circvIRF4 KSHV vIRF4 Human (KSHV-positive
PELs) In vitro
BCBL1, BC1 Cytoplasm and
nucleus
- Toptan et al. (2018)
circPAN/K7.3 KSHV PAN Human (KSHV-positive
PELs) In vitro
BCBL1, BC1 Cytoplasm and
nucleus
- Toptan et al. (2018)
circvIRF4 KSHV vIRF4 In vitro BCBL-1, TIVE, iSLK - During latency two isoforms of circvIRF4 were
generated in each of these cell line models
Ungerleider et al.
(2019)
circBART_1.1 EBV BART Human (EBV-positive
PTLD) In vitro
BC-1 Nucleus CircBARTs were expressed in all EBV tumor latency
stages.
Toptan et al. (2018)
circBART_2.1 EBV BART Human (EBV-positive
PTLD) In vitro
BC-1 Nucleus CircBARTs were expressed in all EBV tumor latency
stages.
Toptan et al. (2018)




CircBARTs were expressed in all EBV tumor latency
stages.
Toptan et al. (2018)




CircBARTs were expressed in all EBV tumor latency
stages.
Toptan et al. (2018)




EBV_circ_RPMS1 was localized in both cytoplasm
and nucleus and may act as a novel viral regulator
of host and/or viral gene expression
Huang et al. (2019)
circRPMS1 EBV RPMS1 Human (NPC tissues)
In vitro
NP69, C666-1, HNE2 Cytoplasm and
nucleus
CircRPMS1 was increased in metastatic
nasopharyngeal carcinoma (NPC). CircRPMS1
targeted to miR-203, miR-31, and miR451,
suggesting that circRPMS1 may function as a
sponge to these three miRNAs.
Liu Q. et al. (2019)
circRPMS1_E4_E3a EBV RPMS1 Human (EBV positive
stomach cancer)
- Nucleus - Ungerleider et al.
(2018)
circRPMS1_E4_E2 EBV RPMS1 Human (EBV positive
stomach cancer)
- Nucleus - Ungerleider et al.
(2018)
circEBNA_U EBV, rLCV EBNA Rhesus SIV/LCV lymphoma
model
- The expression of ebv circEBNA_U in the type III




circRPMS1_E4_E3a EBV RPMS1 Rhesus SIV/LCV lymphoma
model
- - rLCV circRPMS1_E5_E3a and EBV




circRPMS1_E5_E3a rLCV RPMS1 Rhesus SIV/LCV lymphoma
model
- - rLCV circRPMS1_E5_E3a and EBV




circM11_ORF69 MHV68 ORF69 M11 In vitro NIH 3T12 - - Ungerleider et al.
(2019)
circE7 HPV-16 E7 Human (HPV-positive
ASCC)
- - The up-regulation of circE7 RNA was significantly
associated with enhanced survival in ASCC. CircE7




circE7 HPV-16 E7 In vitro In vivo CaSki Cytoplasm The translation of HPV16 circE7 can produce E7
oncoprotein that is crucial for the transformed
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of circRPMS1 led to inhibition of proliferation and invasion
of NPC cells infected with EBV, and induced apoptosis in
these cells. Further investigation suggested that circRPMS1 was
most probably involved in inducing the epithelial-mesenchymal
transition (EMT) in NPC cells and encouraged oncogenesis via
sponging of miR-31, miR-451, and miR-203. Down-regulation of
this circRNA inhibited the aggressiveness and slowed down the
EMT of NPC cells (Liu Q. et al., 2019). These studies suggest
that circRPMS1 may be a potential therapeutic target for EBV-
associated NPC.
Alternative splicing and polyadenylation regulate HPV-RNA
processing during the primary and later-stages of HPV infection.
The polycistronic HPV mRNA transcripts undergo alternative
splicing using various SD and acceptor sites (Johansson and
Schwartz, 2013). In the HPV-16 genome, splicing between
SD site 226 (SD226) and splice acceptor site 409 (SA409)
or SA526 leads to the production of E7 mRNAs, and also
several truncated E6 transcripts (e.g., E6∗I). On the other
hand, preservation of the intron between SD226 and SA409
generates mRNAs that express E6 (Sedman et al., 1991;
Tang et al., 2006; Johansson and Schwartz, 2013). Recently,
circRNAs derived from oncogenic HPV subtypes (HPV-16 and
18) were analyzed using the cancer genome atlas (TCGA)
RNA-Seq data. The presence of back-splicing in the HPV-16
integrated cell lines (SiHa, CaSki, and UPCI:SCC154 cells) was
investigated by inverse PCR. After treatment with RNase R,
HPV-E7 derived circRNA (circE7) was detected in all these
cell lines. Moreover, they detected circE7 in cells that had
been transformed with HPV-16 using both Northern blotting
and inverse RT-PCR, but the analogous HPV-18 circE7 could
not be robustly detected using these techniques. Several lines
of evidence have suggested that circE7 could be translated
into the E7 oncoprotein. The knockdown of circE7 led to a
decreased level of E7 oncoprotein in CaSki cells, and limited
the growth of cancer cells in vitro and tumor xenografts in vivo
(Zhao et al., 2019b).
Chamseddin et al. (2019) compared the role of circE7
as a diagnostic biomarker in ASCC with already established
biomarkers (PD-L1, HPV-ISH, and GLUT1), and the relationship
between these biomarkers and the clinical outcome in ASCC
patients. The circE7 levels were evaluated by RT-qPCR showing
that the high circE7 group (top 50% of patients) had the best
overall survival rate, and this was also correlated with low PD-
L1 expression, positive HPV-ISH, and a better tumor stage
(Chamseddin et al., 2019). Overall, studies have shown that
patients with HPV-16 positive tumors with a high level of circE7
show improved survival compared to HPV-16 positive tumors
with a low level of circE7 (Chamseddin et al., 2019; Zhao et al.,
2019b). Due to its importance, more attention should be given
to role of circE7 as a biomarker in cervical cancer. A number of
other studies are summarized in Table 2.
CONCLUSION
The discovery of non-coding RNAs (such as lncRNA, miRNA,
and circRNA) has provided better understanding of the
mechanisms involved in many physiological and pathological
processes, and has made them the focal point of studies
concerned with their role in cancer, infectious disease (e.g.,
viral infections), and autoimmune diseases. It was previously
thought that circRNAs were only random errors that occurred
during transcription, but today it is known that they are
fundamentally involved in the regulation of gene expression,
and can affect many biological and pathological processes.
However, the entire scope of their functions is still unclear. In
addition, it has been observed that the expression of circRNAs is
altered under different physiological and pathological conditions,
and major changes are significantly associated with the
progression of several diseases, and may serve as a promising
diagnostic biomarker for diseases including viral infections.
Recent studies have confirmed that some host circRNAs
are deregulated in viral infections, and suggest that the
virus uses this cellular mechanism to its advantage. The
fact that members of different viral families are capable of
encoding circRNAs, promises new advances in the scientific
understanding of the diagnosis of viral diseases. Unfortunately,
knowledge about the function, mechanism of formation, and
transportation of VcircRNAs, as well as identification of
the viral genes that encode circRNAs, is still very limited.
However, more research into the function of VcircRNAs
is crucial, since distinguishing between the roles of host
circRNAs and VcircRNAs in viral infection might provide unique
insight in the development of novel therapeutic strategies.
In the future, the potential application of VcircRNAs can be
probably divided into two categories: one being their use
as novel biomarkers for prognosis and diagnosis of viral
diseases. The other is the development of VcircRNA-based
therapeutic approaches which could be useful for deadly
viruses, e.g., Ebola virus and human immunodeficiency virus
(HIV), or for viruses which are highly contagious and spread
rapidly, e.g., novel coronavirus SARS-CoV2. Furthermore,
VcircRNA-based vaccines might represent a highly versatile
platform for development of vaccines against other viruses.
Therefore, further research on circRNAs (especially VcircRNA)
could open a new window of opportunity for the treatment
of deadly diseases, preventing thousands of deaths and
saving a lot of money.
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